These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 19726410)
41. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511 [TBL] [Abstract][Full Text] [Related]
42. Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population. Anfossi M; Colao R; Gallo M; Bernardi L; Conidi ME; Frangipane F; Vasso F; Puccio G; Clodomiro A; Mirabelli M; Curcio SA; Torchia G; Smirne N; Di Lorenzo R; Maletta R; Bruni AC J Alzheimers Dis; 2014; 38(2):351-7. PubMed ID: 23963289 [TBL] [Abstract][Full Text] [Related]
43. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1. Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167 [TBL] [Abstract][Full Text] [Related]
44. Clinical genetics of Parkinson's disease and related disorders. Wider C; Wszolek ZK Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241 [TBL] [Abstract][Full Text] [Related]
45. Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Ortiz-Ortiz MA; Morán JM; Ruiz-Mesa LM; Niso-Santano M; Bravo-SanPedro JM; Gómez-Sánchez R; González-Polo RA; Fuentes JM Neurosci Lett; 2010 Jan; 468(2):120-4. PubMed ID: 19879924 [TBL] [Abstract][Full Text] [Related]
46. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366 [TBL] [Abstract][Full Text] [Related]
47. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers. Vilas D; Shaw LM; Taylor P; Berg D; Brockmann K; Aasly J; Marras C; Pont-Sunyer C; Ríos J; Marek K; Tolosa E Mov Disord; 2016 Jun; 31(6):906-14. PubMed ID: 27041685 [TBL] [Abstract][Full Text] [Related]
48. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease. Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385 [TBL] [Abstract][Full Text] [Related]
54. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Dächsel JC; Mata IF; Ross OA; Taylor JP; Lincoln SJ; Hinkle KM; Huerta C; Ribacoba R; Blazquez M; Alvarez V; Farrer MJ Neurosci Lett; 2006 Dec; 410(2):80-4. PubMed ID: 17095157 [TBL] [Abstract][Full Text] [Related]
55. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Lesage S; Brice A Hum Mol Genet; 2009 Apr; 18(R1):R48-59. PubMed ID: 19297401 [TBL] [Abstract][Full Text] [Related]
56. Progression in the LRRK2-Asssociated Parkinson Disease Population. Saunders-Pullman R; Mirelman A; Alcalay RN; Wang C; Ortega RA; Raymond D; Mejia-Santana H; Orbe-Reilly M; Johannes BA; Thaler A; Ozelius L; Orr-Urtreger A; Marder KS; Giladi N; Bressman SB; JAMA Neurol; 2018 Mar; 75(3):312-319. PubMed ID: 29309488 [TBL] [Abstract][Full Text] [Related]
57. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Büeler H Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005 [TBL] [Abstract][Full Text] [Related]
58. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T; Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455 [TBL] [Abstract][Full Text] [Related]
59. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Gasser T Expert Rev Mol Med; 2009 Jul; 11():e22. PubMed ID: 19631006 [TBL] [Abstract][Full Text] [Related]
60. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers. Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]